Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.515
Delayed Data
As of 3:59pm ET
 -0.027 / -4.98%
Today’s Change
0.34
Today|||52-Week Range
3.98
-67.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

--
Revenue and IncomeNet Revenues97.0K399.0K71.0K--
 
 
 
 
Depreciation And Amortization147.0K99.0K87.0K--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses12.9M21.2M8.8M--
 
 
 
 
Research And Development10.5M17.7M5.7M--
 
 
 
 
Total Operating Expenses13.1M21.3M8.9M--
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.0M-20.9M-8.8M--
 
 
 
 
Extraordinary Credit13.0K0.00----
 
 
Interest Expense On Debt30.0K0.000.00--
 
 
Other Expenses125.0K0.009.0K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.9M-20.9M-8.8M--
 
 
 
 
Preferred Dividend-12.8M-8.6M-4.1M--
 
 
 
 
Net Income-12.9M-20.9M-8.8M--
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.6M10.3M16.4M--
 
 
 
 
Shares To Calculate EPS Diluted4.6M10.3M16.4M--
 
 
 
 
 
Earnings Per ShareEPS-$5.70-$2.88-$0.79--
 
 
 
 
EPS Diluted-$5.70-$2.88-$0.79--
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account